Oncolytics Biotech buy Canaccord Genuity Group Inc.
Start price
06.03.23
/
50%
€1.61
Target price
06.03.24
€4.69
Performance (%)
-
End price
07.03.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncolytics Biotech | - | - | - |
iShares Core DAX® | 4.015% | 2.971% | 16.492% |
iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% |
iShares Nikkei 225® | -0.826% | -5.057% | 14.566% |
iShares S&P 500 | 2.330% | 0.720% | 30.194% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten